Angell asserts that aggregate R&D could be maintained if the pharmaceutical industry were “regarded much as a public utility” (p. 253). Open up companies’ financial books to regulatory ...

West Pharmaceutical Services ... However, growth in demand, especially from biologic customers, and a strong order book for 2023 buoy optimism. The company remains committed to managing its ...

CHAPEL HILL, N.C., Aug. 25, 2011 /PRNewswire/ -- Marketing organizations in highly regulated industries, such as pharmaceuticals and utilities, struggle to incorporate social media into their ...

The pharmaceutical and electric utility industries have spent more on lobbying elected officials than any other industry during the first three months of this year, while Big Agriculture has ...

On September 14, 2023, the Federal Trade Commission (FTC) issued a statement condemning pharmaceutical manufacturers ... or “Orange Book” as it is more commonly known.